Clinical Trial Update: A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 study of MEDI-575 in subjects with recurrent glioblastoma multiforme completed; results were posted on 2017-04-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• MEDI-575

Snippet

Sponsor: MedImmune LLC | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2017-04-06